ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1403	National Cancer Institute	Html	en	Fatigue (PDQ®)–Patient Version	Expert-reviewed information summary about fatigue, a condition marked by extreme tiredness and inability to function because of lack of energy, often seen as a complication of cancer or its treatment.	red blood cells 0.552402 Different cancer treatments 0.470429 biologic therapy 0.483312 severe fatigue 0.621555 cancer treatment-related fatigue 0.636294 blood tests 0.461178 fatigue assessment 0.562053 cancer-related fatigue 0.677281 body 0.472364 PDQ cancer information 0.534931 cancer therapy 0.461118 fatigue 0.963302 health care team 0.495127 clinical trials 0.513612 cancer information summary 0.506469 energy 0.466768 clinical trial 0.50167 cancer survivors 0.464912 fatigue check 0.563522 patients 0.726236 cancer patients 0.600118 moderate-to-severe fatigue 0.551795 cancer diagnosis 0.463516 NCI PDQ cancer 0.473596 radiation therapy 0.547137	cancer fatigue 0.617229 Cancer Patients section 0.478138 problems 0.464163 cancer treatments 0.538547 long-term fatigue 0.571932 therapy cause fatigue 0.601171 anemia-related fatigue 0.55909 Cancer Information Service 0.463488 daily activities 0.501915 National Cancer Institute 0.509064 physical fatigue 0.587544 Palliative Care Editorial 0.466038 Fatigue symptoms 0.572267 advanced cancer 0.469881 Cancer Care page 0.459216 breast cancer 0.487366 Care Editorial Board 0.466889 PDQ summary 0.463007 attention fatigue 0.572542 cancer clinical trials 0.461489 mental fatigue 0.586619 cancer information summaries 0.462137 comprehensive cancer information 0.462211 cancer 0.850092	CLICK HERE
1564	National Cancer Institute	Html	en	Laryngeal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of laryngeal cancer.	treatment 0.456448 cancer treatment 0.208981 vocal cords 0.463035 Laryngeal Cancer Treatment 0.208444 NCI-supported cancer 0.201905 cancer cells 0.32099 stage laryngeal cancer 0.221553 body 0.20156 chemotherapy 0.227934 PDQ cancer information 0.235798 larynx 0.286996 clinical trial search 0.245354 Hyperfractionated radiation therapy 0.214818 laryngeal cancer spreads 0.200731 National Cancer Institute 0.254821 laryngeal cancer 0.644668	clinical trials 0.596105 metastatic laryngeal cancer 0.202273 cancer information summary 0.213869 clinical trial 0.439358 Recurrent laryngeal cancer 0.222324 new treatment 0.207333 patients 0.231814 neck 0.206846 original tumor 0.252057 cancer clinical trials 0.262761 stage 0.247854 lymph nodes 0.238789 lymph node 0.41143 radiation therapy 0.83207 cancer 0.992267	CLICK HERE
1665	National Cancer Institute	Html	null	Last Days of Life (PDQ®)–Patient Version	Expert-reviewed information summary about care during the last days to last hours of life, including common symptoms, ethical dilemmas that may arise, and the role of the oncologist in caring for patients and their families during this time.			CLICK HERE
1672	National Cancer Institute	Html	en	Pediatric Supportive Care (PDQ®)–Patient Version	Expert-reviewed information summary about the unique issues that arise for children during their treatment for cancer, after the completion of treatment, and as adult survivors of cancer.	cancer treatment 0.673763 mental health 0.594918 childhood cancer survivors 0.660763 PDQ cancer information 0.632459 health care team 0.597981 childhood cancer patients 0.499693 children 0.602725 cancer treatment doctors 0.562323 different age groups 0.509717 clinical trials 0.536936 mental health problems 0.576551 early treatment 0.493575 cancer information summary 0.576245 regular mental health 0.520572 NCI PDQ cancer 0.534007 effects 0.524597 supportive care 0.660168 young adults 0.515271 childhood cancer 0.678101 late effects 0.509447 health care support 0.494832 care 0.735246 child 0.686462 end-of-life care 0.567481 parents 0.506649	cancer treatments 0.501032 treatment 0.871904 mental health specialist 0.520368 cancer experience 0.49362 mental health check-ups 0.521913 palliative care 0.553378 Cancer Information Service 0.502777 Follow-up cancer care 0.566023 child end-of-life care 0.503834 National Cancer Institute 0.574409 certain childhood cancer 0.500961 health care 0.604883 Palliative Care Editorial 0.521086 cancer treatment doctor 0.57306 new treatment 0.522928 Cancer Care page 0.512127 Care Editorial Board 0.522941 PDQ summary 0.567319 cancer information summaries 0.506731 cancer patient 0.507833 comprehensive cancer information 0.506663 PDQ Supportive Care 0.533813 cancer 0.997123 follow-up care 0.516276	CLICK HERE
1689	National Cancer Institute	Html	en	Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood central nervous system germ cell tumors.	craniospinal irradiation 0.568926 intracranial germinoma 0.542559 survival rates 0.505415 excellent survival rates 0.497286 endodermal sinus tumor 0.492396 germ cell tumor 0.543477 chemotherapy 0.510034 reduced-volume radiation therapy 0.492394 ifosfamide based chemotherapy 0.484152 Tumors Treatment Overview 0.506029 primordial germ cells 0.489907 focal radiation therapy 0.518434 pure germinomas 0.484971 Radiat Oncol Biol 0.492523 tumor markers 0.56413 radiation therapy doses 0.490668 CNS germ cell 0.55586 tumor markers AFP 0.505621 cerebrospinal tumor markers. 0.502663 conventional whole-brain irradiation 0.482504 whole-ventricular radiation therapy 0.492409 CSF AFP levels 0.509387 nongerminomatous germ cell 0.513106 cell tumor study 0.490435 yolk sac tumor 0.491117	germ cell theory 0.506108 common solid tumor 0.502347 germinomatous germ cell 0.4915 primary chemotherapy 0.487412 radiation therapy 0.751812 et al. 0.485468 Low-dose craniospinal irradiation 0.484891 CNS GCTs 0.523584 whole-ventricle radiation therapy 0.491449 SIOP CNS GCT 0.490345 brain tumor treatment 0.516207 primary brain tumors 0.544753 neoadjuvant chemotherapy results 0.491554 Pediatr Blood Cancer 0.568832 response-based radiation therapy 0.486149 radiation treatment volume 0.488339 boost radiation therapy 0.486976 nervous system tumors 0.483298 Brain Tumor Study 0.49693 Oncol Biol Phys 0.49429 specific chemotherapy regimen 0.484857 intracranial germ cell 0.58985 germ cell tumors 0.911962 radiation therapy fields 0.485192	CLICK HERE
1958	National Cancer Institute	Html	es	Tratamiento del retinoblastoma (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del retinoblastoma en niños.	siguientes procedimientos 0.348249 células madre 0.681334 células madre ayuda 0.327411 pequeña cantidad 0.314739 quimioterapia regional.También 0.356888 siguientes especialistas 0.315369 rayos x 0.316905 huesos.ampliar exploración 0.316446 sección información 0.311156 ondas sonoras 0.352613 efectos tardíos 0.419814 PDQ Efectos tardíos 0.340519 estadio iva 0.318526 tejidos cercanos.ampliar radioterapia 0.346215 quimioterapia sistémica 0.959376 líquido cefalorraquídeo 0.342894 National Cancer Institute 0.310552	retinoblastoma causa efectos 0.427797 estadios iiia 0.316715 Instituto Nacional 0.318729 PDQ Tratamiento 0.331936 determinados cambios 0.322309 International Retinoblastoma Staging 0.571406 Drugs Approved 0.312346 gen rb1 0.821065 Physician Data Query 0.339103 sistema nervioso central 0.324254 posibles efectos 0.313593 Retinoblastoma Staging System 0.572567 siguientes situaciones 0.322957 placa ayuda 0.311711 haz láser 0.317188 siguientes pruebas 0.320835	CLICK HERE
2115	National Cancer Institute	Html	es	Prevención del cáncer de hígado (hepatocelular) (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que influirían en el riesgo de presentar cáncer hepatocelular y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	chronic hepatitis b 0.391786 chronic hepatitis c 0.392121 available online 0.329517 American Cancer Society 0.362594 tt virus dna 0.321147 largo plazo 0.314356 with hepatocellular carcinoma 0.362577 hepatitis e 0.456465 CHC agudo 0.334135 denominación hepatitis no-A 0.402257 hepatocellular carcinoma 0.818192 Concurrent hepatitis 0.385001 Instituto Nacional 0.321684 Qidong hepatitis 0.385791 patients with chronic 0.340288 hígado llamada cirrosis 0.31992 hepatitis nanb 0.397414 risk factors 0.334046 hepatitis b 0.815878 hepatitis c 0.64216 Estados Unidos 0.516836 virus hepáticos forma 0.324783 Universal hepatitis 0.404867 Spanish patients with 0.316748 PDQ Prevención 0.319178	patients with 0.420437 carcinoma among patients 0.322468 SEER Cancer Statistics 0.314302 Rizzetto M 0.316034 Infect Dis 0.316615 virus carriers with 0.326772 natural history 0.314507 Ningún virus 0.321223 hepatocelular factores causales 0.320088 Viral Hepatitis FAQs 0.396943 National Cancer Institute 0.335176 La hepatitis 0.94804 Chang MH 0.316907 viral hepatitis 0.515061 Yuan JM 0.316452 GB virus 0.317604 correlate with expression 0.314623 Long-term phlebotomy with 0.314798 Liver Int 0.354023 Hepatocellular carcinoma without 0.326846 chronic hepatitis 0.450334 hepatitis aguda 0.53174 hepatitis tipos 0.394509 virus rna 0.317794	CLICK HERE
2974	National Cancer Institute	Video	en	Challenge: Fitting fitness into your busy schedule	Life can get really hectic sometimes. Between work, family and other obligations, it's hard to find time to exercise. But before you say you don't have time to exercise each day, consider this: even a little bit of exercise is better than no exercise at all!	little bit 0.820288 fitness 0.392435 work 0.370295 obligations 0.461065	Life 0.388039 exercise 0.667358 time 0.674488 family 0.369813	CLICK HERE
3570	National Cancer Institute	Html	en	The NCI Outstanding Investigator Award (R35)	The NCI Outstanding Investigator Award (OIA) supports investigators with outstanding records of productivity in cancer research by providing extended funding stability and encouraging investigators to continue or embark on projects of unusual potential in cancer research.	direct costs 0.516422 projects 0.339999 person months effort 0.510514 OIA 0.56501 greater risks 0.517599 Institution 0.338577 outstanding productivity 0.586579 cancer research 0.764353 funded investigators 0.583615	Award 0.340824 NCI Outstanding Investigator 0.903247 outstanding records 0.61157 recipient 0.352813 Principal Investigator 0.547103 PI 0.388963 substantial time 0.526242 NCI grant 0.541618 salary support 0.509963	CLICK HERE
17242	National Cancer Institute	Html	en	National Cryo-Electron Microscopy Facility Team Members	The National Cryo-Electron Microscopy Facility team is responsible for the operational activities of NCEF. Find team member bios and a list of NCEF working group members.	strategic oversight 0.549362 Lab Advisory Committee 0.88433 Frederick National Lab 0.883241 NCEF Senior Microscopist 0.757617 Molecular Virology 0.5561 government contract projects 0.639164 cancer researchers. 0.551348 Piermaria J. Oddone 0.648956 Thomas Edwards 0.534246 cryo-EM laboratories 0.7289 Grant J. Jensen 0.61562 advisory committee members 0.653176 research expertise 0.57237 PMP certification 0.536505 structural biology 0.656766 Advanced Computer Studies 0.527736 L. Mario Amzel 0.617619 NCEF Scientific Project 0.683141 Biophysics Section 0.560804 Stephen C. Harrison 0.611643 structural studies 0.552951 resolution cryo-electron microscopy 0.682528 structural biology communities 0.646732 academic research 0.551259 Hopkins University School 0.630222	Steven J. Ludtke 0.641874 cryo-EM services 0.763943 Senior Investigator 0.530394 Physical Biochemistry 0.552108 Infectious Disease research 0.655231 Sriram Subramaniam 0.554662 Angela M. Gronenborn 0.615627 Ph.D 0.61505 Hong Zhou 0.531963 core team 0.649969 structural analysis 0.55203 Ulrich Baxa 0.572356 Edward H. Egelman 0.618207 Cancer Research 0.549211 NCEF Microscopist 0.616796 National Lab Advisory 0.882693 adjunct faculty appointments 0.637399 strong background 0.529367 Cell Biology 0.534261 Project Management 0.649065 National Cryo-EM Facility 0.904008 Helen Wang 0.529981 single particle cryo-EM 0.833864 electron tomography 0.5462	CLICK HERE